Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

NCT04903184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid-19

Interventions

BIOLOGICAL: RUTI® vaccine
BIOLOGICAL: Placebo

Sponsor

RUTI Immunotherapeutics S.L.